UBS Group AG - Sep 30, 2024 Form SCHEDULE 13G Schedule Report for Amneal Pharmaceuticals, Inc. (AMRX)

Filing Manager: UBS Group AG
Reporting Manager: UBS Group AG
Security: Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 per share
Symbol: AMRX
Shares outstanding: 311M shares
Disclosed Ownership: 21.5M shares
Ownership: 6.9%
Form type: SCHEDULE 13G
Date filed: 10/30/2024, 11:04 AM
Date of event: Sep 30, 2024
Next filing: Feb 10, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
UBS Group AG	6.9%	21.5M	0	14.7K	Andrew Johnson	Director